Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > This is what Pez said on June 17

<< Previous

Bullboard Posts

Next >>

Comment by Rarbar99on Sep 30, 2021 10:16am

66 Views

Post# 33943103

RE:RE:This is what Pez said on June 17

It's not about being wrong, it's about spewing false facts and refusing to listen to the other side. The whole reason why Pez is attacking me is because I was bearish when I came here and he couldn't stand it. Same reason why he is attacking Yukon and every other bear.

"The science can't be denied"

is that why the trial is being delayed by 12 months?

best part is that he has been wrong EVERY TIME. Yukon was right all along.